Hypera HYPMY Stock
Hypera Price Chart
Hypera HYPMY Financial and Trading Overview
| Hypera stock price | 4.22 USD |
| Previous Close | 4.13 USD |
| Open | 4.21 USD |
| Bid | 4.21 USD x 114500 |
| Ask | 4.22 USD x 98500 |
| Day's Range | 4.2 - 4.21 USD |
| 52 Week Range | 3.71 - 5.5 USD |
| Volume | 46.45K USD |
| Avg. Volume | 22.06K USD |
| Market Cap | 2.97B USD |
| Beta (5Y Monthly) | 0.105 |
| PE Ratio (TTM) | 8.274509 |
| EPS (TTM) | 0.51 USD |
| Forward Dividend & Yield | 0.21 (4.96%) |
| Ex-Dividend Date | July 6, 2026 |
| 1y Target Est | N/A |
HYPMY Valuation Measures
| Enterprise Value | 8.86B USD |
| Trailing P/E | 8.274509 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.3368769 |
| Price/Book (mrq) | 1.0808022 |
| Enterprise Value/Revenue | 1.005 |
| Enterprise Value/EBITDA | 3.247 |
Trading Information
Hypera Stock Price History
| Beta (5Y Monthly) | 0.105 |
| 52-Week Change | -1.86% |
| S&P500 52-Week Change | 21.71% |
| 52 Week High | 5.5 USD |
| 52 Week Low | 3.71 USD |
| 50-Day Moving Average | 4.11 USD |
| 200-Day Moving Average | 4.41 USD |
HYPMY Share Statistics
| Avg. Volume (3 month) | 22.06K USD |
| Avg. Daily Volume (10-Days) | 16.2K USD |
| Shares Outstanding | 703.99M |
| Float | 300.08M |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0.010% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 1.105 |
| Trailing Annual Dividend Yield | 26.75% |
| 5 Year Average Dividend Yield | 337.00% |
| Payout Ratio | 0.4377 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 19.82% |
| Operating Margin (ttm) | 28.82% |
| Gross Margin | 61.17% |
| EBITDA Margin | 30.93% |
Management Effectiveness
| Return on Assets (ttm) | 6.32% |
| Return on Equity (ttm) | 13.16% |
Income Statement
| Revenue (ttm) | 8.82B USD |
| Revenue Per Share (ttm) | 13.53 USD |
| Quarterly Revenue Growth (yoy) | 8.50% |
| Gross Profit (ttm) | 5.39B USD |
| EBITDA | 2.73B USD |
| Net Income Avi to Common (ttm) | 1.74B USD |
| Diluted EPS (ttm) | 0.51 |
| Quarterly Earnings Growth (yoy) | 14.89% |
Balance Sheet
| Total Cash (mrq) | 1.58B USD |
| Total Cash Per Share (mrq) | 2.25 USD |
| Total Debt (mrq) | 7.48B USD |
| Total Debt/Equity (mrq) | 51.85 USD |
| Current Ratio (mrq) | 1.858 |
| Book Value Per Share (mrq) | 3.9045072 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 2.9B USD |
| Levered Free Cash Flow (ttm) | 751.98M USD |
Profile of Hypera
| Country | United States |
| State | SP |
| City | São Paulo |
| Address | Av. Magalhães de Castro, 4800 |
| ZIP | 05676-120 |
| Phone | N/A |
| Website | https://www.hypera.com.br |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 10564 |
Hypera S.A. operates as a pharmaceutical company in Brazil. The company provides sweeteners products under the Adocyl, finn, and Zero-cal brands; analgesics and anti-inflammatories products under the Doril, Atroveran, Calminex, Alivium, Buscopan, Buscofem, geloll, Torsilax, Neosaldina, and naprohax brands; cold and flu remedies and decongestants products under BENEGRIO, Rinosoro, Blu, Neosoro, Coristina, APRACUR, and Fluviral brands. It offers antihistamines products under Alektos, Histamin, Polaramine, PredSim, and Desrinite brands; antiseptics products under Merthiolate brand; Herbal medicine products under Maracugina, Eparema, Tamarine, and Naturetti brands; gastrointestinal products under Dramin, Estomazil, Engov, Lacto-purga, gastrol, Epocler, Bifilax, and Pepsamar brands. In addition, the company provides generics products under neo quimica brand; skicare products under episol, epidrat, simple organic, and bioage brands; supplements and vitamins products Addera, Biotonico Fontoura, Colflex, and Vitasay brands; and other products under Nebacetin, Cepacol, ESCABIN, Mirrorelax, Ammy, Nesina, and Diprospan brands. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. was founded in 1999 and is headquartered in São Paulo, Brazil.
Q&A For Hypera Stock
What is a current HYPMY stock price?
Hypera HYPMY stock price today per share is 4.22 USD.
How to purchase Hypera stock?
You can buy HYPMY shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Hypera?
The stock symbol or ticker of Hypera is HYPMY.
Which industry does the Hypera company belong to?
The Hypera industry is Drug Manufacturers - Specialty & Generic.
How many shares does Hypera have in circulation?
The max supply of Hypera shares is 703.99M.
What is Hypera Price to Earnings Ratio (PE Ratio)?
Hypera PE Ratio is 8.27450900 now.
What was Hypera earnings per share over the trailing 12 months (TTM)?
Hypera EPS is 0.51 USD over the trailing 12 months.
Which sector does the Hypera company belong to?
The Hypera sector is Healthcare.
